Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Hepatitis Drugs Market Research Reports

Titlepublishedprice

Global Hepatitis Partnering 2010 to 2017

By Current Partnering
"...... he Global Hepatitis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • ......"
01-Feb-2017$1495

United States Hepatitis Drugs Market Report 2017

By QYResearch Group
"...... player, covering - F. Hoffmann-La Roche - Gilead Sciences - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - Vertex Pharmaceuticals - Abbvie - Achillion Pharmaceuticals - ......"
10-Jan-2017$3800

Global Hepatitis Drugs Market Professional Survey Report 2017

By QYResearch Group
"...... ion, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - F. H......"
05-Jan-2017$3500

Global Hepatitis Drugs Market Research Report 2017

By QYResearch Group
"...... obal market, with capacity, production, price, revenue and market share for each manufacturer, covering - F. Hoffmann-La Roche - Gilead Sciences - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis ......"
04-Jan-2017$2900

Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... stand the market and pipeline status of the drugs around the Hepatitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides th......"
01-Jan-2017$2000

Telavic -Drug Insights, 2017

By Delve Insight
"...... des the Telavic sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Telavic, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Victrelis -Drug Insights, 2017

By Delve Insight
"...... provides the Victrelis sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Victrelis, patents information and exclusivity data, route of synthesis, competi......"
01-Jan-2017$1000

ViraferonPeg -Drug Insights, 2017

By Delve Insight
"...... and also provides the ViraferonPeg sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of ViraferonPeg, patents information and exclusivity data, route of syn......"
01-Jan-2017$1000

Viread -Drug Insights, 2017

By Delve Insight
"...... the Viread sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Viread, patents information and exclusivity data, route of synthesis, competitive landscape,......"
01-Jan-2017$1000

Hepatitis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.